Molecules (Jun 2020)

1-(1-Arylethylpiperidin-4-yl)thymine Analogs as Antimycobacterial TMPK Inhibitors

  • Yanlin Jian,
  • Fabian Hulpia,
  • Martijn D. P. Risseeuw,
  • He Eun Forbes,
  • Guy Caljon,
  • Hélène Munier-Lehmann,
  • Helena I. M. Boshoff,
  • Serge Van Calenbergh

DOI
https://doi.org/10.3390/molecules25122805
Journal volume & issue
Vol. 25, no. 12
p. 2805

Abstract

Read online

A series of Mycobacterium tuberculosis TMPK (MtbTMPK) inhibitors based on a reported compound 3 were synthesized and evaluated for their capacity to inhibit MtbTMPK catalytic activity and the growth of a virulent M. tuberculosis strain (H37Rv). Modifications of the scaffold of 3 failed to afford substantial improvements in MtbTMPK inhibitory activity and antimycobacterial activity. Optimization of the substitution pattern of the D ring of 3 resulted in compound 21j with improved MtbTMPK inhibitory potency (three-fold) and H37Rv growth inhibitory activity (two-fold). Moving the 3-chloro substituent of 21j to the para-position afforded isomer 21h, which, despite a 10-fold increase in IC50-value, displayed promising whole cell activity (minimum inhibitory concentration (MIC) = 12.5 μM).

Keywords